No easy road to outsmart cancer
Hopes of greatly speeding up the evaluation of new therapies by using tumour response to a short course of neoadjuvant treatment as a surrogate for clinical benefit have proved false and the sooner we recognise [more]
Hopes of greatly speeding up the evaluation of new therapies by using tumour response to a short course of neoadjuvant treatment as a surrogate for clinical benefit have proved false and the sooner we recognise [more]
Every patient wants to be cured. But a culture that defines success as cure’ condemns many patients and doctors to failure. What does treatment ‘success’ mean in cancer? Does it only mean curing the cancer? [more]